Skip to content
Studies have shown that active fund managers routinely underperform the S&P500 index*
Home
Articles
WALL STREET X
Forecasts
Portfolios
Wall Street X
Articles
Forecasts
Portfolios
Search
Results for
{phrase}
(
{results_count}
of
{results_count_total}
)
Displaying
{results_count}
results of
{results_count_total}
Janux Therapeutics, Inc. (NASDAQ: JANX)
JANX Stock Predictions and Ratings
WSX Rating:
STRONG SELL
WSX Forecast (1yr):
-80.70%
Analyst Rating:
BUY
Analyst Forecast (1yr):
244.90%
JANX Stock Analysis
JANX
PE Ratio:
JANX
PEG Ratio:
Not Available
JANX
Forward EPS Growth (12 month):
0.00%
JANX
PS Ratio:
60.3
JANX
PSG Ratio:
-0.8
JANX
Forward Revenue Growth (12 month):
-75.30%
JANX Articles
No data was found